Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7951–8000 of 75459
On July 19, 2024, Charles B. Lobetti, III, Chief Financial Officer (“CFO”) and principal accounting officer of Healthcare Integrated Technologies, Inc. (the “Company”) notified the Company of his decision to resign, effective as of July 31, 2024 (the “Effective Date”), in order to pursue other business opportunities.
Salvatore Rinaldi, the Company’s Chief Operating Officer, notified the Company’s Chief Executive Officer and the Board of Directors on July 24, 2024 that he would be retiring from his role as Chief Operating Officer of the Company and of Needham Bank once his successor is identified and appointed as Chief Operating Officer and begins employment with Needham Bank.
On July 22, 2024, Bjoern Klaas, Vice President and General Manager of the EMEA region, exited his position as vice president and is no longer an executive officer of Proto Labs, Inc.
Barry Diller, Alexis Herman and Marc Bolland, three members of the Board of Directors (the “Board”) of The Coca-Cola Company (the “Company”), each notified the Company of his or her decision to retire from the Board, effective August 1, 2024.
Barry Diller, Alexis Herman and Marc Bolland, three members of the Board of Directors (the “Board”) of The Coca-Cola Company (the “Company”), each notified the Company of his or her decision to retire from the Board, effective August 1, 2024.
Barry Diller, Alexis Herman and Marc Bolland, three members of the Board of Directors (the “Board”) of The Coca-Cola Company (the “Company”), each notified the Company of his or her decision to retire from the Board, effective August 1, 2024.
retirement of Beth Ann L. Chivinski, Fulton's Interim Chief Financial Officer, on December 31, 2024
On July 23, 2024, John Barrett and Gerald Adolph notified Cintas Corporation (the Company) of their decisions not to stand for re-election at the Company’s 2024 annual meeting of shareholders (the 2024 Annual Meeting).
On July 23, 2024, John Barrett and Gerald Adolph notified Cintas Corporation (the Company) of their decisions not to stand for re-election at the Company’s 2024 annual meeting of shareholders (the 2024 Annual Meeting).
On July 17, 2024, Vincent Stoquart resigned as a member of the board of directors
On July 23, 2024, Kojiro (Koji) Hatano notified our Board of his decision to resign from the Board, effective as of the First Closing of the share repurchase.
the Board determined Mr. Chumbley's retirement would be effective July 26, 2024
On July 23, 2024, FactSet Research Systems Inc. (the “Company”) announced that Linda S. Huber had transitioned out of her position as the Company’s Executive Vice President, Chief Financial Officer, effective July 22, 2024.
Dr. Jack Syage, the Company’s Chief Scientific Officer, President and member of the Board, whereby he tendered his resignation from the role of Chief Scientific Officer of the Company, effective immediately.
On July 17, 2024, Richard W. Roedel informed BrightView Holdings, Inc. (the “Company”) that he was resigning from the Company’s Board of Directors (the “Board”), effective December 31, 2024.
Brandon Nelson, who joined JetBlue in 2005 and has served as the Company's General Counsel and Corporate Secretary since 2018, will depart from these positions with the Company, effective August 5, 2024
On July 23, 2024, Lyft, Inc. (the “Company”) announced that Kristin Sverchek, the Company’s President, and the Company agreed to terms pursuant to which Ms. Sverchek will depart the Company as an employee effective August 20, 2024.
due to disagreements regarding salaries due and payable, Mr. Chow has informed the Company that he is suspending his work as CFO.
On July 22, 2024, Douglas Branch resigned his position as a member of the Board of Directors of Hour Loop, Inc.
On July 17, 2024, Gustavo P. Aguiar resigned as the Chief Financial Officer (serving as the principal financial and accounting officer) and Treasurer of Atlas Lithium Corporation
In connection with the closing of the Lexington Transaction, on July 22, 2024, the Company notified Pierre Caloz, the Company’s Chief Operating Officer, that his employment was being terminated consistent with the terms of the employment agreement by and between uniQure biopharma B.V. and Mr. Caloz, dated May 17, 2021.
On July 22, 2024, David Johnson, the Chief Financial Officer (“CFO”) and Chief Accounting Officer (“CAO”) of Atkore Inc. (the “Company”), notified the Company that he is resigning from the Company to pursue another opportunity outside the electrical industry.
On July 19, 2024, Robert Langer and Stephen Berenson each notified Moderna, Inc. (the “Company”) of his resignation from the Board of Directors of the Company (the “Board”), including all committees on which he serves, effective August 5, 2024.
On July 19, 2024, Robert Langer and Stephen Berenson each notified Moderna, Inc. (the “Company”) of his resignation from the Board of Directors of the Company (the “Board”), including all committees on which he serves, effective August 5, 2024.
Effective July 17, 2024, Sherri Adams resigned as an officer and director of the Company to pursue other business interests.
Effective July 17, 2024, Sherri Adams resigned as an officer and director of the Company to pursue other business interests.
On July 17, 2024, Duncan Grazier, the Chief Technology Officer of WM Technology, Inc., a Delaware corporation (the “Company”), tendered his resignation from his role as Chief Technology Officer, effective July 31, 2024.
Derrick Pratt will depart from his role as the Company’s Chief Operating Officer, effective June 30, 2024.
On July 20, 2024, Mr. Victor Peng, President, AMD, notified Advanced Micro Devices, Inc. (the “Company”) of his intention to retire from the Company, effective August 30, 2024.
On July 16, 2024, Mr. G. Maliek Ferebee, the Chief Human Resources Officer of DLH Holdings Corp. (the “Company”), notified the Company that he has decided to resign his position with the Company effective August 23, 2024, in order to pursue a new career opportunity.
Patrick T. Hagerty, Executive Vice President and Chief Commercial Officer of Performance Food Group Company (the “Company”) notified the Company of his intention to retire and resign from his position as Executive Vice President and Chief Commercial Officer.
On July 17, 2024, Crestview Partners IV GP, L.P. and affiliated entities (the “Crestview Parties”) notified the Board of Directors (“Board”) of Viad Corp (the “Company”) of their intent to remove Sung-Chul Patrick T. LaValley as a member of the Board, effective immediately.
On July 19, 2024, Jay Lichter, Ph.D. resigned as a member of the Board of Directors (the “Board”) of Janux Therapeutics, Inc. (the “Company”), including his chairmanship of the Board, effective as of such date.
David M. Urso, our President and Chief Executive Officer, and Richard G. Ghalie, M.D., our Chief Medical Officer, will be leaving the Company effective August 1, 2024.
David M. Urso, our President and Chief Executive Officer, and Richard G. Ghalie, M.D., our Chief Medical Officer, will be leaving the Company effective August 1, 2024.
Charles V. Baltic III, the current Chairperson of the Board, will also step down from the Board effective immediately.
Vicky A. Bailey, Sarah M. Barpoulis, Kenneth M. Burke, Diana M. Charletta, Thomas F. Karam, D. Mark Leland, Norman J. Szydlowski and Robert F. Vagt resigned as directors of Equitrans
Vicky A. Bailey, Sarah M. Barpoulis, Kenneth M. Burke, Diana M. Charletta, Thomas F. Karam, D. Mark Leland, Norman J. Szydlowski and Robert F. Vagt resigned as directors of Equitrans
Vicky A. Bailey, Sarah M. Barpoulis, Kenneth M. Burke, Diana M. Charletta, Thomas F. Karam, D. Mark Leland, Norman J. Szydlowski and Robert F. Vagt resigned as directors of Equitrans
Vicky A. Bailey, Sarah M. Barpoulis, Kenneth M. Burke, Diana M. Charletta, Thomas F. Karam, D. Mark Leland, Norman J. Szydlowski and Robert F. Vagt resigned as directors of Equitrans
each of Diana M. Charletta, principal executive officer of Equitrans, Kirk R. Oliver, principal financial officer of Equitrans, Brian P. Pietrandrea, principal accounting officer of Equitrans, and each other named executive officer of Equitrans ceased his or her respective service as an officer of Equitrans.
each of Diana M. Charletta, principal executive officer of Equitrans, Kirk R. Oliver, principal financial officer of Equitrans, Brian P. Pietrandrea, principal accounting officer of Equitrans, and each other named executive officer of Equitrans ceased his or her respective service as an officer of Equitrans.
each of Diana M. Charletta, principal executive officer of Equitrans, Kirk R. Oliver, principal financial officer of Equitrans, Brian P. Pietrandrea, principal accounting officer of Equitrans, and each other named executive officer of Equitrans ceased his or her respective service as an officer of Equitrans.
Vicky A. Bailey, Sarah M. Barpoulis, Kenneth M. Burke, Diana M. Charletta, Thomas F. Karam, D. Mark Leland, Norman J. Szydlowski and Robert F. Vagt resigned as directors of Equitrans
Vicky A. Bailey, Sarah M. Barpoulis, Kenneth M. Burke, Diana M. Charletta, Thomas F. Karam, D. Mark Leland, Norman J. Szydlowski and Robert F. Vagt resigned as directors of Equitrans
Vicky A. Bailey, Sarah M. Barpoulis, Kenneth M. Burke, Diana M. Charletta, Thomas F. Karam, D. Mark Leland, Norman J. Szydlowski and Robert F. Vagt resigned as directors of Equitrans
Vicky A. Bailey, Sarah M. Barpoulis, Kenneth M. Burke, Diana M. Charletta, Thomas F. Karam, D. Mark Leland, Norman J. Szydlowski and Robert F. Vagt resigned as directors of Equitrans
Effective as of July 18, 2024 (the “Separation Date”), Alan W. Young ceased to serve as the Senior Vice President and Chief Procurement Officer of Spirit AeroSystems Holdings, Inc.
On July 17, 2024, iSpecimen Inc. (the “Company”) received a written notice from Andrew L. Ross that he will be resigning as a director of the Company, effective July 25, 2024.
On July 18, 2024, Dr. Samir J. Serhan resigned as the Chief Operating Officer of Air Products and Chemicals, Inc. (the “Company”), effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.